Stay updated with breaking news from Groupb Strep. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GENEVA — The World Health Organisation(WHO) unveiled a plan on Tuesday to bring meningitis under control by 2030, slashing the 250,000 annual deaths caused by the debilitating disease.Launching the first-ever global strategy to tackle the illness, the WHO said it wanted to eliminate epidemics of bacterial meningitis — the most deadly form.By doing so, it hopes to halve the
Babies surviving GBS disease ‘more likely to need special educational support’ (Danny Lawson/PA) Babies who survive a potentially deadly disease caused by a common type of bacteria passed on from their mothers may be twice as likely to have life-changing disabilities and require special educational support than those not infected, research suggests. Scientists in the UK and Europe found infants who develop invasive Group B Streptococcus (GBS) disease during the first days and months of their lives are at risk of having lasting neurodevelopmental impairments (NDI) – disabilities in the f...
Scroll through our gallery of photos above to see more... Little Logan (main image above) was born at 00:04 on February 23, after an unusual pregnancy. Mum Carrie Lane said Logan was nearly born at 26 weeks after her waters broke and there was a Group B Strep infection, so she had three helicopter rides to Portsmouth for treatment, but in the end she made it to 34 weeks. After birth, Logan spent 16 days in the Special Care Baby Unit on the Island. Carrie said: “I’d like to thank the maternity team for all the midwives who went through this rocky journey with myself and little Log...
Share this article HOUSTON, Feb. 17, 2021 /PRNewswire/ -- Vax-Immune Diagnostics announces today it has received CE Mark approval for its first-in-class medical device, LabReady® GBS. LabReady's Group B Strep product is the first in Vax-Immune Diagnostics' lineup of women's health solutions that helps avoid life-threatening complications and expensive consequences for mothers and their babies. With CE Mark approval, LabReady is now available to European physicians, patients, and hospital systems. The brainchild of Dr. Leonard E. Weisman, renowned neonatologist, LabReady aims to protect...
Nearly 90% of hospitals across the UK are not using the recommended £11 test to detect whether pregnant women are carrying a potentially-deadly bacteria, new data has revealed. Failure to follow the national guidelines to prevent Group B Strep (GBS) infections is causing a “postcode lottery” of care and opportunities, the Group B Strep Support charity said. A freedom of information investigation by the charity found just 13% of NHS trusts and boards in the UK used the GBS-specific enriched culture medium (ECM) when testing women late in pregnancy, in line with guidelines from Public Heal...